临床实践
Copyright ©The Author(s) 2022.
世界华人消化杂志. 2022-03-08; 30(5): 242-248
在线出版 2022-03-08. doi: 10.11569/wcjd.v30.i5.242
表1 基线资料
组别n女性年龄(岁)BMI(kg/m2)ASA分级Ⅰ级饮酒史n(%)吸烟史n(%)
A组5525(45.45)70.71±3.2335.01±0.6630(54.55)15(27.27)20(36.36)
B组5427(50.00)71.12±2.7835.12±0.5928(51.85)14(25.93)23(42.60)
C组5423(42.59)69.89±3.8934.96±0.6131(57.41)19(35.18)21(38.89)
F/χ20.6071.9100.9380.3361.3030.448
P0.7380.1510.3930.8450.5210.800
表2 生命体征(mean±SD)
项目组别nT0T1T2T3T4
MAP(mmHg)A组55106.68±12.53104.43±11.5692.35±9.5391.06±8.87106.81±11.42
B组54107.13±11.55105.11±10.0697.72±9.9695.55±10.12107.52±10.03
C组54105.59±12.06104.68±10.4398.24±10.1297.05±10.77106.66±11.59
F0.2330.0565.9455.3660.094
P0.7920.9450.0030.0060.911
HR(次/min)A组5575.92±6.4877.11±5.5988.83±8.8590.21±9.5176.78±6.53
B组5475.85±6.6376.89±5.8182.16±7.7185.52±8.1275.56±7.02
C组5477.05±5.5477.02±5.6380.95±8.4584.61±7.7476.12±6.71
F0.6310.02114.1046.8340.446
P0.5330.9800.0000.0010.641
表3 BIS值、VAS评分(mean±SD)
组别nBIS
清醒后VAS评分(分)
检查前5 min检查中检查后5 min
A组5595.83±8.8148.85±4.4586.62±4.112.58±0.61
B组5494.49±9.5654.01±5.0687.12±3.892.05±0.51
C组5496.12±7.1256.38±4.1285.59±4.221.96±0.48
F0.55838.9361.98021.293
P0.5730.0000.1420.000
表4 MMSE评分(mean±SD, 分)
组别n检查前5 min清醒后tP
A组5526.95±0.5325.95±0.5110.0830.000
B组5427.02±0.4825.44±0.3319.9330.000
C组5427.10±0.4124.82±0.3829.9710.000
F1.353101.585
P0.2610.000
表5 麻醉相关指标(mean±SD, min)
组别n苏醒时间无痛胃镜检查时间麻醉起效时间麻醉恢复时间
A组557.64±1.2112.51±0.852.18±0.2112.44±1.30
B组546.41±1.0210.12±0.221.40±0.0810.53±1.28
C组547.88±1.3213.36±0.702.23±0.2412.70±1.31
F23.756361.262325.01145.180
P0.0000.0000.0000.000
表6 内镜医师及患者满意度(mean±SD, 分)
组别n内镜医师患者
A组5595.95±1.214.55±0.20
B组5496.13±1.334.60±0.17
C组5496.24±1.084.64±0.25
F0.7982.532
P0.4520.083
表7 不良反应n(%)
组别n低氧血症严重呼吸暂停事件恶心呕吐
A组551(1.82)0(0.00)2(3.64)
B组543(5.56)0(0.00)4(7.41)
C组547(12.96)4(7.41)7(12.96)
χ25.5618.2773.265
P0.0620.0160.196

引文著录: 黄晓敏, 陈颖, 任晓听. 不同剂量芬太尼联合酮咯酸氨丁三醇在老年肥胖无痛胃镜中的应用. 世界华人消化杂志 2022; 30(5): 242-248